Konstantinos Kalogeropoulos is an Assistant Professor at the Department of Biotechnology and Biomedicine, Technical University of Denmark (DTU), leading research at the Cell Diversity Lab. His work bridges proteomics, computational biology, and snake venom research. Current projects: "The Proteomic Landscape during Influenza Infection" (2022-2025) Supervisor for PhD projects on protease network rewiring in psoriasis and wound exudate degradomics Research interests include: Proteomic analysis of inflammatory diseases Snake venom toxin structure prediction Extracellular matrix biomechanics De novo peptide sequencing algorithms Computational modeling of protease networks Recent article trends demonstrate his work in • Database-free proteomics (InstaNovo/InstaNexus) • Snake venom pathophysiology (V-ToCs clustering) • Inflammatory disease biomarkers (psoriasis, impaired healing) • Extracellular matrix mechanics (fibronectin tension, gut inflammation) Advising: Supervises PhD students Polhaus, C. J. M. and Haack, A. M., focusing on protease networks and wound healing.
Birgitte Zeuner is an Associate Professor at the Department of Biotechnology and Biomedicine , Technical University of Denmark, specializing in Protein Chemistry and Enzyme Technology . Her research focuses on Enzymatic Synthesis Technology with particular emphasis on carbohydrate-active enzymes. Active supervisor in Engineering alkenal reductase reversibility (2025-2028) Main supervisor in Regioselectivity in enzymatic carbohydrate synthesis (2024-2027) Supervisor in Enzymatic xyloglucan modification (2018-2022) Recent 54 publications highlight her work on glycosylation, human milk oligosaccharides, and transglycosylation. She has received significant attention in Mendeley readership and peer review platforms. Current projects explore: Enzyme engineering for biomass upgrading Sustainable biocatalytic processes using ionic liquids Gut microbiome interactions with plant-derived carbohydrates Her research aligns with UN Sustainable Development Goals for biocatalytic applications in health and sustainability.
Anne Zebitz Eriksen is an Assistant Professor at the Department of Health Technology, Technical University of Denmark (DTU), specializing in Cell and Drug Technologies within Tailored Materials and Tissues. Her research integrates pharmaceutical science, biomedical engineering, and ophthalmology to develop advanced drug delivery systems and nanocarriers. University: Technical University of Denmark Department: Health Technology Academic Rank: Assistant Professor Research Interests: Her work focuses on liposome engineering, membrane translocation mechanisms, ocular drug delivery, and 3D stem cell-derived organoids. She actively contributes to addressing challenges in diabetic retinopathy, viral infections (e.g., SARS-CoV-2), and intestinal bioavailability. Article Trends: Recent publications highlight her expertise in lipid-based nanocarriers, ocular pharmacokinetics, and organoid models. Key themes include peptide transport optimization, antiviral protocols, and bioprinting perfusable vasculatures for tissue engineering. Supervision & Collaboration: She supervises PhD projects on microsystems for tissue actuation and bioprinted vasculatures, collaborating with institutions like DTU Health Tech. Her research aligns with UN SDGs for health and well-being, emphasizing innovative drug delivery solutions.
Katrine Lindholm Bøgh is a Professor and Head of the Research Group for Food Allergy at the National Food Institute, Technical University of Denmark (DTU). Her work focuses on developing diagnostic, preventive, and therapeutic strategies for food allergies, with a specific emphasis on understanding how physicochemical properties of food proteins influence allergy development versus tolerance. She leads interdisciplinary research at the intersection of immunology, food science, and sustainable nutrition. Current affiliations: DTU National Food Institute, Research Group for Food Allergy Academic rank: Professor Her research integrates Food Allergy , Molecular Allergology , and Allergenicity Assessment to investigate immune mechanisms triggered by protein modifications (e.g., hydrolysis, heat treatment) and exposure routes. She has pioneered studies on Alternative Protein Sources like insect, rapeseed, and microalgae to evaluate allergenic risks in sustainable foods. Recent publications highlight trends in European Union novel food approvals (2025) and mechanistic insights into cow’s milk allergy models (2024). Key themes include Sublingual Immunotherapy , Brown Norway Rat Models , and Protein Processing Effects on allergenicity. She supervises PhD students Yue S.R. and Shafie B., and leads major projects like: ALLEVIATE2: Novel food allergy immunotherapy strategies ALLPreT: Allergenicity Prediction Toolbox for novel foods SAFEPRO: Sustainable protein sources for future diets Her work aligns with UN Sustainable Development Goals (SDG 2, SDG 3), and she actively participates in international conferences and media outreach about food allergy risks in innovative protein sources.
Professor Ákos T. Kovács at the Technical University of Denmark focuses on bacterial interaction and evolution, particularly in Bacillus subtilis and its ecology within biofilms and rhizospheres. His research integrates green and white biotechnology applications. Current affiliations: Department of Biotechnology and Biomedicine, DTU Microbes Initiative Previous roles: Independent Research Group Leader (University of Jena), Post-doctoral researcher (University of Groningen, Biological Research Centre Szeged) Research spans: Bacterial-fungal interactions Biofilm sociomicrobiology Secondary metabolite evolution Soil microorganism ecology Recent publications highlight synthetic microbiomes for plant growth, prophage dynamics in Bacilli, and pigment biosynthesis mechanisms. Collaborations span institutions like University of Copenhagen, Ljubljana, and Jena. Supervised active PhD projects include microbial signaling in rhizospheres and genomic analysis of Bacillus genera.
Asger Bach Lund serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. His institutional address is Blegdamsvej 3, 2200 Copenhagen N, Denmark, affiliated with Region Hovedstaden (Region H) healthcare system. Dr. Lund's research focuses on endocrine physiology with specialization in gut-derived hormones, particularly proglucagon-derived peptides (GLP-1, GIP, GLP-2), their roles in metabolic regulation, and therapeutic applications for diabetes and obesity. His work investigates intestinal hormone expression patterns, amino acid-stimulated secretion dynamics, and molecular mechanisms underlying bariatric surgery outcomes. Analysis of his recent publications reveals dominant research trends in mucosal transcriptomics, pancreatic alpha cell function, and gut-bone axis interactions. His studies frequently employ human physiological models, translational mouse-human comparisons, and advanced molecular techniques to explore metabolic pathways. Lund maintains extensive collaborative networks within Copenhagen's endocrine research community, particularly with the Knop and Holst research groups. His work appears in high-impact journals including Cell Reports Medicine , Gut , and Physiological Reviews , demonstrating significant contributions to metabolic disease research.
Jakob Lykke Andersen is an Associate Professor in the Department of Mathematics and Computer Science at the University of Southern Denmark (SDU), where he conducts research in algorithms with applications in cheminformatics and complex systems. He also holds a former external appointment as a Research Fellow at the Tokyo Institute of Technology (2015–2017). Research Interests: His work lies at the intersection of computer science and theoretical chemistry, focusing on algorithmic methods for analyzing chemical reaction networks. He employs hypergraphs, mixed-integer linear programming, and probabilistic models to study metabolic pathways, reaction databases, and prebiotic systems. His research emphasizes computational efficiency, formal modeling, and software implementation. Publication Trends: His recent publications (2019–2025) show a consistent focus on graph-based modeling of chemical systems, rule extraction from reaction databases, thermodynamic feasibility, and stochastic analysis. These works appear in high-impact journals in cheminformatics, bioinformatics, and complex systems, reflecting strong interdisciplinary collaboration. Scientific Contributions: While no specific awards are listed, his sustained research output and leadership in funded projects highlight significant contributions to algorithmic cheminformatics. Grants and Projects: He is actively involved in two major ongoing research projects: (1) Software Infrastructures for Teaching at Scale (funded by Innovation Fund Denmark, 2022–2025), and (2) DIREC (Danish Research Center for Digital Economy, 2020–2025), indicating active engagement in both educational technology and core computational research. Advising and Outreach: While no students are listed, he participates in academic advising through project supervision. He contributes to public discourse through media appearances on topics such as mathematics in health (e.g., intestinal system modeling in obesity) and educational well-being. Labs and Teams: He collaborates with interdisciplinary teams, including researchers from bioinformatics, chemistry, and computer science, particularly through projects involving Merkle, Flamm, Fagerberg, and Stadler. His work is associated with algorithmic cheminformatics and software framework development groups at SDU.
Ruben Vazquez Uribe is a Co-Principal Investigator at the Bacterial Synthetic Biology Section, Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark (DTU). His research is centered on developing programmable microbial therapeutics for metabolic and inflammatory diseases, leveraging synthetic biology and microbiome engineering. Research Interests: His work spans bacterial synthetic biology, microbiome modulation, engineered probiotics, oral delivery of peptides, and AI applications in drug discovery. He focuses on conditions like metabolic diseases, cancer cachexia, and NAFLD, aiming to develop living microbial medicines with precise therapeutic functions. The recent articles highlight a strong trend toward advanced microbiome therapeutics , combining synthetic biology with gut microbiome manipulation. Key themes include engineering Saccharomyces boulardii and Escherichia coli for enhanced delivery and immunomodulation, using AI to accelerate screening, and applying metagenomics to isolate novel gut microbes. These efforts reflect a multidisciplinary approach integrating biotechnology, computational methods, and translational medicine. Scientific Contributions: Co-PI in multiple long-term research projects since 2015. Supervisor for four active PhD projects on microbiome therapeutics and cancer. Host and guest lecturer in national and international academic events. Advising and Grants: He actively supervises PhD students across projects related to microbiome synthetic biology and personalized medicine. He is involved in research funded by the Novo Nordisk Foundation, contributing to high-impact publications and innovative therapeutic platforms. His team collaborates widely across Europe, focusing on translational microbiome applications. Labs and Teams: He leads research within the Bacterial Synthetic Biology Section at DTU Biosustain, a center dedicated to sustainable biotechnology. The team specializes in engineering microbial consortia, developing synthetic genetic circuits, and translating findings into clinical applications.
Niels Erik Olesen is a Postdoc researcher at the Department of Biotechnology and Biomedicine, Technical University of Denmark (DTU), affiliated with the Nano Bio Integrated Systems group. He serves as Contact Person for the DTU project "Active Wearable Sensors for Monitoring of Levodopa in Parkinson’s Disease" (2023-2025) and is a Member of the International Electrotechnical Commission (2022-2026). His ORCID profile (0009-0001-3908-5043) and institutional email nieol@dtu.dk confirm his active DTU affiliation. Research interests center on electrochemical sensors and drug delivery systems. Early work (2012-2018) focused on biopharmaceutics, including thermodynamic modeling of cyclodextrin formulations, bile salt interactions, and drug-polymer solubility prediction using DSC/ITC techniques. Current research pivots to wearable sensor technology, specifically microneedle-based porous gold electrochemical sensors for real-time levodopa monitoring in Parkinson's disease patients, as evidenced by his active project and 2024 conference presentation. His 15 most recent publications (2015-2018) reveal strong methodological innovation in pharmaceutical formulation science. Key themes include DSC-based solubility prediction (7 articles), cyclodextrin-bile salt displacement mechanisms (4 articles), and polymer molecular weight effects on drug miscibility (3 articles). The shift toward electrochemical sensors is documented in his 2023 project but not yet reflected in publications, indicating emerging research direction. No scientific awards or fellowships were mentioned in the provided sources. Olesen leads the DTU research project on Parkinson's disease wearable sensors (100% focus on levodopa monitoring) and presented preliminary work as Guest Lecturer at a conference in November 2024. No student advisement is documented, though his project involves interdisciplinary collaboration. The International Electrotechnical Commission membership (2022-2026) suggests industry-standardization contributions. He operates within DTU's Nano Bio Integrated Systems group, focusing on nanoscale biointegration. His current project team develops microneedle-based electrochemical sensors for continuous levodopa monitoring, aiming to translate lab research into clinical Parkinson's management tools through wearable technology.
Kerstin Skovgaard is a Senior Researcher at the Department of Biotechnology and Biomedicine , Technical University of Denmark . Her work focuses on antiviral immunology with emphasis on zoonotic influenza viruses and metabolic syndrome's impact on infection severity . She develops translational animal models for innate immune research in respiratory infections and post-traumatic conditions . Research Interests Antiviral Immunology of influenza A viruses and PEDV Metabolic Syndrome and obesity-related immunity Translational models for respiratory diseases and gut-brain axis miRNA profiling in equine osteoarthritis and porcine infections Immunomodulatory diets with algae and probiotics Biomarker discovery through proteomics and RT-qPCR Scientific Contributions include 202+ publications across influenza , gut immunity , and joint inflammation . Her recent 15 articles demonstrate expertise in porcine models for human diseases , with emphasis on innate immune responses , miRNA dynamics , and metabolic-immune interactions . Supervision includes PhD students : J. Pina Agullet B. L. Henriksen C. J. M. Polhaus H. A. Laybourn C. López-Figueroa Methodologies encompass microfluidic qPCR , RNA-Seq , and advanced in vitro systems . Her research supports UN Sustainable Development Goals through cost-efficient diagnostics and therapeutic development .
Albin Gustav Sandelin is a Professor in the Department of Biology at the University of Copenhagen, specializing in bioinformatics and RNA biology. With a PhD in Functional Genomics from Karolinska Institute (2004) and an MSc in Molecular Biology from Stockholm University (2000), his career spans roles at institutions including RIKEN Yokohama Institute and Tokyo Medical and Dental University. His research focuses on Gene regulation mechanisms Transcription start site dynamics RNA sequencing methodologies Promoter architecture analysis Cancer microenvironment interactions . Recent publications highlight his work in pancreatic cancer adaptation to acidic environments (2024-2025), TLDR-seq for RNA analysis, and JASPAR database development. He supervises PhD students including Eivind Valen and Eric Man-Hung, with a history of teaching bioinformatics courses at Karolinska Institute and Copenhagen University. Key collaborations involve institutions in Japan, Canada, and Sweden, with ongoing contributions to open-access genomic resources like JASPAR.
Anna Billeschou Bomholt is a Research Fellow at the Department of Biomedical Sciences , University of Copenhagen. Her work spans multiple research areas including renal physiology, vascular biology, metabolic disorders, and gastrointestinal health. Her research focuses on: Role of glucagon and GLP-2 receptors in kidney and intestinal injury Metabolic regulation through hormonal signaling Mouse models for studying diabetes complications and chemotherapy effects Development of experimental protocols for epithelial regeneration Key trends in her publications (2019–2024) include: Investigations into glucagon receptor's impact on renal hemodynamics and lipid metabolism Validation of receptor antibodies and signaling pathways Pharmacological approaches to intestinal regeneration via TGR5 and GLP-2 Longitudinal studies on receptor agonism/antagonism effects
Professor Anette Müllertz is a distinguished researcher and academic at the Department of Pharmacy, Faculty of Health and Medical Sciences (SUND), University of Copenhagen, Denmark. She serves as Director of The Bioneer-FARMA Center and leads the Research Group for Rational Oral Drug Delivery (RODD group). With a PhD in Engineering, Professor Müllertz has established herself as a leading expert in oral drug delivery systems, particularly for poorly soluble compounds. Her educational background includes a PhD from DTU (Technical University of Denmark), and she has held various academic positions including Professor (current), Associate Professor at the Faculty of Pharmaceutical Sciences (FARMA), and Research Scientist at Novo Nordisk A/S. Professor Müllertz's research focuses on innovative approaches to enhance drug delivery of small molecules, with special emphasis on lipid-based drug delivery systems. Her work spans from developing biorelevant gastrointestinal media and digestion models to studying absorption mechanisms and conducting bioavailability studies. She has pioneered methods for simulating gastrointestinal conditions and has made significant contributions to understanding how lipid formulations can improve the solubility and absorption of poorly soluble drugs. Her research group has been instrumental in developing predictive in vitro models that correlate with in vivo performance, addressing one of the major challenges in pharmaceutical development. The work has significant implications for improving drug efficacy and reducing development costs for pharmaceutical companies. 2005 American Association of Pharmaceutical Scientist's Lipid-Based Drug Delivery Award 2009 FARMA prize for raising most funding She has supervised 23 PhD students (9 ongoing), co-supervised 7 PhD students (1 ongoing), and mentored numerous postdoctoral researchers. Her teaching responsibilities include advanced courses on drug delivery and human digestion and absorption. Professor Müllertz leads multiple research initiatives including the IMI EU consortium OrBiTo, the Villum Kann Rasmussen Centre of Excellence "Namec," and collaborates with major pharmaceutical companies through various consortia. Her work is supported by substantial funding from public and private sources, totaling millions of Danish kroner.
Ditte Lynge Clement serves as a Researcher at the University of Copenhagen's Faculty of Health and Medical Sciences within the Department of Biomedical Sciences. She is actively affiliated with the reNEW stem cell research center and the Jensen Lab, conducting cutting-edge work in gastrointestinal biology and regenerative medicine from her base at Blegdamsvej 3B in Copenhagen. Her research focuses on cellular and molecular mechanisms in gastrointestinal systems, with particular emphasis on organoid modeling of colon, intestinal, and gastric tissues. Key interests include extracellular matrix interactions in cancer progression, CRISPR-Cas9 screening for epithelial maturation regulators, and deep visual proteomics for phenotypic analysis. Her work bridges fundamental cell biology with translational applications in cancer and regenerative medicine. Analysis of her publication record (2013-2025) reveals a clear trajectory toward increasingly sophisticated organoid-based modeling, with recent work (2023-2025) integrating proteomics and genetic screening to uncover mechanisms of cellular phenotype switching and tumor escape. Earlier studies established foundational work in fibroblast migration and sebaceous gland development. Clement operates within the collaborative ecosystem of the Jensen Lab at the University of Copenhagen, which specializes in stem cell biology and tissue regeneration. Her work benefits from integration with the reNEW international stem cell research center, facilitating cross-institutional collaborations evident in her co-authorship on high-impact publications across multiple continents.
Alvise Vianello is an Associate Professor at the Department of the Built Environment within the Faculty of Engineering and Science at Aalborg University. His primary affiliation is with the Urban Pollution Research Group and the Division of Civil and Environmental Engineering. He focuses on microplastic pollution, environmental engineering, and water quality assessment. Research interests include microplastic distribution in coastal waters, urban runoff management, and their impacts on ecosystems and human health. Active in developing analytical tools like the siMPle software for microplastic identification. Collaborates internationally, with recent work in Norway, Italy, and the Canary Islands. His research highlights the prevalence of microplastics in marine environments, including their migration patterns, interactions with organisms, and human exposure pathways. Key areas include tyre wear particles in urban runoff, microplastic accumulation in sediments, and their association with intestinal inflammation biomarkers. Recent studies emphasize the tripled microplastic deposition on seafloors over two decades and the health risks of airborne microplastics in indoor environments. His work has been covered in over 67 media outlets, underscoring societal relevance. Grants and collaborations involve environmental agencies and universities, with datasets contributing to open-source research tools. He leads the Urban Pollution Research Group, focusing on interdisciplinary solutions to anthropogenic pollution challenges.
